ABOS Acumen Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ABOS

Price (delayed)

$2.55

Market cap

$184.41M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.63

Enterprise value

$156.3M

?
Relative Growth: Rel. Growth: 10
Relative Strength: Rel. Strength: 76
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 8
Highlights
Acumen Pharmaceuticals's EPS has increased by 29% YoY and by 12% from the previous quarter
Acumen Pharmaceuticals's net income has increased by 23% YoY and by 7% from the previous quarter
The company's quick ratio has shrunk by 59% YoY and by 46% QoQ
The company's equity has shrunk by 51% YoY and by 35% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.acumenpharm.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of ABOS

ABOS stock price

How has the Acumen Pharmaceuticals stock price performed over time
Intraday
1.59%
1 week
11.84%
1 month
-3.41%
1 year
100.79%
YTD
20.85%
QTD
-4.49%

Financial performance

How have Acumen Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$105.42M
Net income
-$105.04M
Gross margin
N/A
Net margin
N/A
Acumen Pharmaceuticals's operating income has increased by 27% YoY and by 8% QoQ
Acumen Pharmaceuticals's net income has increased by 23% YoY and by 7% from the previous quarter

Price vs fundamentals

How does ABOS's price correlate with its fundamentals

Growth

What is Acumen Pharmaceuticals's growth rate over time

Valuation

What is Acumen Pharmaceuticals stock price valuation
P/E
N/A
P/B
3.22
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Acumen Pharmaceuticals's EPS has increased by 29% YoY and by 12% from the previous quarter
The P/B is 168% more than the 5-year quarterly average of 1.2 and 53% more than the last 4 quarters average of 2.1
The company's equity has shrunk by 51% YoY and by 35% QoQ

Efficiency

How efficient is Acumen Pharmaceuticals business performance
ABOS's ROIC has plunged by 97% YoY and by 23% from the previous quarter
ABOS's return on equity has dropped by 67% year-on-year and by 11% since the previous quarter
ABOS's ROA is down by 32% year-on-year and by 2.8% since the previous quarter

Dividends

What is ABOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABOS.

Financial health

How did Acumen Pharmaceuticals financials performed over time
Acumen Pharmaceuticals's total assets is 97% more than its total liabilities
ABOS's current ratio has dropped by 59% year-on-year and by 46% since the previous quarter
The company's quick ratio has shrunk by 59% YoY and by 46% QoQ
The company's debt is 45% lower than its equity
The debt to equity has soared by 112% YoY and by 57% from the previous quarter
The company's equity has shrunk by 51% YoY and by 35% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.